rs41303344

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_032119.4(ADGRV1):​c.746G>A​(p.Arg249Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00936 in 1,609,410 control chromosomes in the GnomAD database, including 95 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. R249R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0065 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0097 ( 88 hom. )

Consequence

ADGRV1
NM_032119.4 missense

Scores

1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1U:1B:14

Conservation

PhyloP100: 2.15

Publications

14 publications found
Variant links:
Genes affected
ADGRV1 (HGNC:17416): (adhesion G protein-coupled receptor V1) This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008]
ADGRV1 Gene-Disease associations (from GenCC):
  • Usher syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 2C
    Inheritance: AR Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • febrile seizures, familial, 4
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0045897663).
BP6
Variant 5-90627284-G-A is Benign according to our data. Variant chr5-90627284-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 46374.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0065 (987/151812) while in subpopulation NFE AF = 0.0108 (735/67898). AF 95% confidence interval is 0.0102. There are 7 homozygotes in GnomAd4. There are 453 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADGRV1NM_032119.4 linkc.746G>A p.Arg249Lys missense_variant Exon 7 of 90 ENST00000405460.9 NP_115495.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADGRV1ENST00000405460.9 linkc.746G>A p.Arg249Lys missense_variant Exon 7 of 90 1 NM_032119.4 ENSP00000384582.2
ADGRV1ENST00000640281.1 linkn.805G>A non_coding_transcript_exon_variant Exon 7 of 7 1
ADGRV1ENST00000640083.1 linkn.451G>A non_coding_transcript_exon_variant Exon 5 of 6 5
ADGRV1ENST00000640109.1 linkn.842G>A non_coding_transcript_exon_variant Exon 7 of 9 5

Frequencies

GnomAD3 genomes
AF:
0.00651
AC:
987
AN:
151694
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00143
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00407
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00333
Gnomad FIN
AF:
0.00872
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0108
Gnomad OTH
AF:
0.00577
GnomAD2 exomes
AF:
0.00639
AC:
1581
AN:
247404
AF XY:
0.00667
show subpopulations
Gnomad AFR exome
AF:
0.00149
Gnomad AMR exome
AF:
0.00404
Gnomad ASJ exome
AF:
0.00233
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00880
Gnomad NFE exome
AF:
0.00955
Gnomad OTH exome
AF:
0.00684
GnomAD4 exome
AF:
0.00966
AC:
14074
AN:
1457598
Hom.:
88
Cov.:
30
AF XY:
0.00930
AC XY:
6742
AN XY:
724650
show subpopulations
African (AFR)
AF:
0.00144
AC:
48
AN:
33388
American (AMR)
AF:
0.00437
AC:
195
AN:
44572
Ashkenazi Jewish (ASJ)
AF:
0.00336
AC:
87
AN:
25928
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39642
South Asian (SAS)
AF:
0.00370
AC:
317
AN:
85790
European-Finnish (FIN)
AF:
0.00766
AC:
408
AN:
53238
Middle Eastern (MID)
AF:
0.00157
AC:
9
AN:
5746
European-Non Finnish (NFE)
AF:
0.0113
AC:
12509
AN:
1109068
Other (OTH)
AF:
0.00832
AC:
501
AN:
60226
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
673
1347
2020
2694
3367
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
484
968
1452
1936
2420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00650
AC:
987
AN:
151812
Hom.:
7
Cov.:
32
AF XY:
0.00610
AC XY:
453
AN XY:
74218
show subpopulations
African (AFR)
AF:
0.00143
AC:
59
AN:
41396
American (AMR)
AF:
0.00407
AC:
62
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5138
South Asian (SAS)
AF:
0.00333
AC:
16
AN:
4802
European-Finnish (FIN)
AF:
0.00872
AC:
92
AN:
10554
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0108
AC:
735
AN:
67898
Other (OTH)
AF:
0.00571
AC:
12
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
54
109
163
218
272
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00887
Hom.:
11
Bravo
AF:
0.00597
TwinsUK
AF:
0.0116
AC:
43
ALSPAC
AF:
0.00986
AC:
38
ESP6500AA
AF:
0.00137
AC:
5
ESP6500EA
AF:
0.0121
AC:
99
ExAC
AF:
0.00611
AC:
738
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00961
EpiControl
AF:
0.00778

ClinVar

Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Uncertain:1Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:8
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ADGRV1: BP4, BS1, BS2 -

Jun 21, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 19, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28041643, 32581362) -

Aug 09, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:5
Mar 26, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Arg249Lys in exon 7 of GPR98: This variant is not expected to have clinical sign ificance because it has been identified in 1.17% (77/6554) of European American chromosomes and 0.17% (5/2954) of African American chromosomes in a broad popula tion by the NHLBI Exome sequencing project (http://evs.gs.washington.edu/EVS/; d bSNP rs41303344). -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 02, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: ADGRV1 c.746G>A (p.Arg249Lys) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0064 in 247404 control chromosomes, predominantly at a frequency of 0.0096 within the Non-Finnish European subpopulation in the gnomAD database, including 9 homozygotes. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 2 fold of the estimated maximal expected allele frequency for a pathogenic variant in ADGRV1 causing Usher Syndrome phenotype (0.0054), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. c.746G>A has been reported in the literature in one individual affected with Inherited Retinal Disease (Carss_2017). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 28041643, 32420686, 33089500). ClinVar contains an entry for this variant (Variation ID: 46374). Based on the evidence outlined above, the variant was classified as likely benign. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 19, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome Pathogenic:1
Jan 01, 2015
NIHR Bioresource Rare Diseases, University of Cambridge
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

Retinal dystrophy Uncertain:1
Jan 01, 2023
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg
Significance:Uncertain significance
Review Status:flagged submission
Collection Method:clinical testing

- -

Usher syndrome type 2C Benign:1
Apr 08, 2025
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
18
DANN
Benign
0.97
DEOGEN2
Benign
0.13
T;T
Eigen
Benign
-0.19
Eigen_PC
Benign
-0.047
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.53
.;T
MetaRNN
Benign
0.0046
T;T
MetaSVM
Benign
-1.1
T
PhyloP100
2.1
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-1.1
.;N
REVEL
Benign
0.035
Sift
Benign
0.26
.;T
Sift4G
Benign
0.23
.;T
Polyphen
0.0060
B;B
Vest4
0.18
MVP
0.40
MPC
0.11
ClinPred
0.0064
T
GERP RS
4.0
Varity_R
0.070
gMVP
0.49
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41303344; hg19: chr5-89923101; COSMIC: COSV105343921; COSMIC: COSV105343921; API